Navigation Links
Five Questions About Protopic (tacrolimus) Ointment
Date:8/3/2009

CHICAGO, Aug. 3 /PRNewswire/ -- Known medically as atopic dermatitis (AD), eczema is characterized by dry, itchy skin and rashes.(1) Scratching the affected area of skin may result in redness, swelling, scaling, cracking, weeping of clear fluid, and crusting of the skin.(2) Immuno-modulators called topical calcineurin (cal-SEE-nur-in) inhibitors (TCIs) can be effective treatments for patients with mild, moderate or severe eczema(3) who fail to respond adequately to first-line prescription treatments, such as topical corticosteroids, or when those treatments are not advisable. Applied to the affected area of skin, TCIs can reduce the signs and symptoms of eczema.

One of the TCIs currently on the market is called Protopic Ointment. Protopic is a prescription ointment used to treat moderate to severe eczema in adults or children two years of age or older who have a normal immune system. Protopic is for use after other prescription medicines have not worked or when a doctor recommends that other prescription medicines should not be used. Protopic should be used for short periods and, if needed, treatment may be repeated after breaks. Protopic can be a valuable part of an overall treatment strategy for managing moderate to severe AD, which also includes a proper skin care regimen and avoiding substances such as foods, detergents and fabrics that may trigger a flare.

How is Protopic used?

Protopic ointment is a prescription medicine used on the skin to treat moderate to severe eczema for short periods, and, if needed, may be repeated with breaks in between.(4) After first-line treatments, or when those treatments are not advisable, Protopic has been shown to be safe and effective in sensitive and/or difficult to treat areas when used as directed.

Is Protopic suitable for children?

Protopic is available in two concentrations: 0.1% and 0.03%. Either concentration can be used in adults, while only the 0.03% concentration is indicated for children between the ages of 2 and 15. Protopic should not be used in children under the age of 2.(5)

What clinical studies were conducted to support the approval of Protopic?

Three randomized, double-blinded, clinical studies using un-medicated ointment were conducted to support approval of Protopic and demonstrate its safety and effectiveness in treating adults and children with moderate to severe eczema.(7,8,9)

In the adult studies of 632 patients, a significantly greater number of patients achieved at least a 90% or better improvement of their eczema with either the 0.1% or 0.03% concentrations of Protopic, based on their physician's global assessment, at 12 weeks compared to those patients who were treated with an un-medicated ointment.(8)

Similarly, a study of 351 patients ages 2 to 15 showed that a significantly greater number of patients had at least 90% or more improvement with Protopic, based on physician global assessment, compared with an un-medicated ointment.(9) Only Protopic Ointment 0.03% is indicated for children aged 2 to 15 years.

These clinical trials also showed that both pediatric and adult eczema patients who used Protopic had an itch reduction 5 times greater than those who used an un-medicated ointment.(8,9)

What is the important safety information for Protopic?

Protopic should not be used by patients who are allergic to any of its ingredients. The most common side effects with the use of Protopic are sensation of skin burning or itching, flu-like symptoms and headaches. Patients using Protopic should avoid natural or artificial sunlight (sun lamps or tanning beds). Patients should not use Protopic if they have a skin infection on the area of skin to be treated. The skin being treated should not be covered with bandages, dressings, or wraps.

As with all prescription medications, patients should talk with their doctor about their medical history, other health conditions and any other prescription, over-the-counter or natural medicines they may be using. Patients also should tell their doctor if they have a skin disease called Netherton's syndrome, or skin infections such as chicken pox or herpes or if they've been told they have a weakened immune system, or are pregnant, breast feeding or planning to become pregnant.(11)

Important Information Patients Should Know About Protopic Ointment

The safety of using Protopic Ointment for a long period of time is not known. A very small number of people who have used Protopic Ointment have had cancer (for example, skin or lymphoma). However, a link with Protopic Ointment has not been shown. Because of this concern, patients should:

  • Not use Protopic Ointment continuously for a long time
  • Use Protopic Ointment only on areas of skin that have eczema
  • Not use Protopic Ointment on a child under 2 years old(12)

If the eczema does not improve within six weeks, patients should contact their doctor.

Visit www.protopic.com for more information including full prescribing information.

References

  1. Handout on Health: Atopic Dermatitis. National Institute of Arthritis and Muscoskeletal and Skin Diseases. NIH Publication No. 03-4272. Revised April 2003, page 3
  2. Eczema/Atopic Dermatitis, American Academy of Dermatology web site. http//www.aad.org/public/publications/pamphlets/skin_eczema.html. Accessed October 21, 2008, page 1
  3. Handout on Health: Atopic Dermatitis. National Institute of Arthritis and Muscoskeletal and Skin Diseases. NIH Publication No. 03-4272. Revised April 2003, page 3
  4. Protopic(R) (tacrolimus) Ointment full Prescribing Information, Deerfield, Ill., Astellas Pharma US, Inc. 2006
  5. Protopic(R) (tacrolimus) Ointment full Prescribing Information, Deerfield, Ill., Astellas Pharma US, Inc. 2006
  6. Protopic Ointment full Prescribing Information, ibid.
  7. Soter N, et al. J Am Acad Dermatol. 2001;44;S39-46.
  8. Hanfin, J, et al. J Am Acad Dermatol. 2001;44:S28-S38.
  9. Paller A, et al. J Am Acad Dermatol. 2001;44:S47-S57
  10. Protopic Ointment full Prescribing Information, op. cit.
  11. Protopic Ointment full Prescribing Information, op. cit.
  12. Protopic Ointment full Prescribing Information, op. cit.


'/>"/>
SOURCE Astellas Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions
2. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
3. NeurogesX Responds to EMEAs Day 120 Questions
4. Americans United for Life: Obamas Disbanding Bioethics Council Raises Troubling Questions
5. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
6. Stevens researchers provide new information about mass spectrometry
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
9. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
10. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
11. Montana State University lab gives early warnings about biological invaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
Breaking Biology News(10 mins):